Trial Details

COMPLETED
Basic Information
Clinical ID c4504
Identifier NCT00409682
Trial Title Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Crohn's Disease
Interventions BIOLOGICAL: Adalimumab|BIOLOGICAL: Adalimumab|BIOLOGICAL: Adalimumab
Participant Information
Sponsor Abbott
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2007-04
Primary Completion Date 2010-05
Completion Date 2010-05